Delivery Order SPE2DB22D1017-SPE2DB25FG8BB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,620 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units, with an ultimate completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,048.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam (10 gm) on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical and medical supply procurement program. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,096.00 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.24 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries firm fixed pricing. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit, valued at $1,445.61. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. The award was made on a competitive basis without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,034.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside competitive award with a completion date of September 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8BBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply transaction within the company's broader relationship with federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medications and medical commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains through competitive awards and flexible contract vehicles managed by the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |